You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

58 Items

Surgical, Radiation, and Systemic Treatments of Patients with Thymic Epithelial Tumours

Document Status: Current
ID: 7-11
Version: 3

Mar 2022

Systemic Therapy for Recurrent Epithelial Ovarian Cancer

Document Status: Current
ID: 4-3
Version: 4

Jul 2017

Systemic Therapy for Recurrent, Metastatic, or Persistent Cervical Cancer

Document Status: Current
ID: 4-20
Version: 2

Nov 2014

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Document Status: Current
ID: 7-A-2022-1-17v3
Version: 3

Oct 2023

Systemic Therapy in the Curative Treatment of Head and Neck Squamous Cell Cancer

Document Status: Current
ID: 5-11
Version: 2

Jan 2022

Systemic Treatment Computerized Prescriber Order Entry (ST CPOE): Best Practice Guideline for Intravenous and Oral Chemotherapy

Document Status: Current
ID: GL-C50-26

Feb 2016

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Document Status: Current
ID: GL END 2-31

Jul 2018

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-3

Feb 2021

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-2
Version: N/A

Jan 2020

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

Document Status: Current
ID: GL 1-22-A
Version: 2

Jul 2022